Criterion Capital Advisors LLC Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Criterion Capital Advisors LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,729 shares of the healthcare conglomerate’s stock after purchasing an additional 159 shares during the quarter. UnitedHealth Group accounts for 1.6% of Criterion Capital Advisors LLC’s investment portfolio, making the stock its 16th biggest position. Criterion Capital Advisors LLC’s holdings in UnitedHealth Group were worth $2,340,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also modified their holdings of UNH. Richelieu Gestion SA purchased a new position in UnitedHealth Group in the fourth quarter valued at about $26,000. CGC Financial Services LLC grew its position in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares in the last quarter. True Wealth Design LLC bought a new position in UnitedHealth Group during the 4th quarter valued at $31,000. LFA Lugano Financial Advisors SA raised its stake in shares of UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares in the last quarter. Finally, Transcendent Capital Group LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at about $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of several research reports. Piper Sandler lifted their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. TD Cowen dropped their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Morgan Stanley dropped their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. Finally, Barclays raised their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Trading Up 4.7 %

Shares of NYSE:UNH opened at $509.26 on Friday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The firm has a fifty day moving average of $498.34 and a two-hundred day moving average of $501.96. The firm has a market capitalization of $468.72 billion, a P/E ratio of 31.13, a price-to-earnings-growth ratio of 1.48 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period last year, the business earned $6.26 EPS. The business’s quarterly revenue was up 8.6% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a $2.10 dividend. The ex-dividend date was Monday, June 17th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.